Green Cross Corporation (006280.KS)
KRW 168000.0
(-1.7%)
KRW 168000.0
(-1.7%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 84.89 Billion KRW | -77.46% |
| 2022 | 376.54 Billion KRW | 1.41% |
| 2021 | 371.31 Billion KRW | 40.35% |
| 2020 | 264.55 Billion KRW | -22.83% |
| 2019 | 342.81 Billion KRW | 30.19% |
| 2018 | 263.31 Billion KRW | -14.23% |
| 2017 | 306.98 Billion KRW | 105.28% |
| 2016 | 149.54 Billion KRW | 102.09% |
| 2015 | 74 Billion KRW | 94.61% |
| 2014 | 38.02 Billion KRW | 84.68% |
| 2013 | 20.59 Billion KRW | 153.28% |
| 2012 | 8.12 Billion KRW | -12.32% |
| 2011 | 9.27 Billion KRW | -77.93% |
| 2010 | 42.01 Billion KRW | -43.2% |
| 2009 | 73.96 Billion KRW | -3.67% |
| 2008 | 76.78 Billion KRW | 70.64% |
| 2007 | 45 Billion KRW | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 344.37 Billion KRW | 40.96% |
| 2024 Q1 | 244.31 Billion KRW | 187.8% |
| 2023 Q2 | 183.52 Billion KRW | -49.6% |
| 2023 Q4 | 84.89 Billion KRW | -54.8% |
| 2023 Q3 | 187.81 Billion KRW | 2.34% |
| 2023 FY | 84.89 Billion KRW | -77.46% |
| 2023 Q1 | 364.16 Billion KRW | -3.29% |
| 2022 FY | 483.2 Billion KRW | 1.41% |
| 2022 Q4 | 376.54 Billion KRW | -2.65% |
| 2022 Q3 | 386.8 Billion KRW | 0.42% |
| 2022 Q2 | 385.19 Billion KRW | 1.44% |
| 2022 Q1 | 379.72 Billion KRW | 2.26% |
| 2021 Q2 | 343.73 Billion KRW | 29.98% |
| 2021 Q1 | 264.45 Billion KRW | -0.04% |
| 2021 Q4 | 371.31 Billion KRW | 8.14% |
| 2021 FY | 434.71 Billion KRW | 40.35% |
| 2021 Q3 | 343.35 Billion KRW | -0.11% |
| 2020 Q4 | 264.55 Billion KRW | 4.88% |
| 2020 FY | 218.82 Billion KRW | -22.83% |
| 2020 Q1 | 346.81 Billion KRW | 1.17% |
| 2020 Q2 | 253.98 Billion KRW | -26.77% |
| 2020 Q3 | 252.23 Billion KRW | -0.69% |
| 2019 Q4 | 342.81 Billion KRW | 18.22% |
| 2019 Q3 | 289.99 Billion KRW | -5.76% |
| 2019 Q1 | 273.92 Billion KRW | 4.03% |
| 2019 Q2 | 307.71 Billion KRW | 12.34% |
| 2019 FY | 469.65 Billion KRW | 30.19% |
| 2018 Q4 | 263.31 Billion KRW | 0.1% |
| 2018 Q3 | 263.04 Billion KRW | 0.17% |
| 2018 FY | 414.87 Billion KRW | -14.23% |
| 2018 Q1 | 322.25 Billion KRW | 4.97% |
| 2018 Q2 | 262.59 Billion KRW | -18.51% |
| 2017 Q4 | 306.98 Billion KRW | 0.06% |
| 2017 Q3 | 306.8 Billion KRW | -0.11% |
| 2017 FY | 450.65 Billion KRW | 105.28% |
| 2017 Q1 | 149.58 Billion KRW | 0.03% |
| 2017 Q2 | 307.12 Billion KRW | 105.32% |
| 2016 Q3 | 149.5 Billion KRW | 0.0% |
| 2016 FY | 251.05 Billion KRW | 102.09% |
| 2016 Q4 | 149.54 Billion KRW | 0.03% |
| 2016 Q1 | 40 Billion KRW | -45.95% |
| 2016 Q2 | - KRW | -100.0% |
| 2015 Q1 | 99 Billion KRW | 160.36% |
| 2015 Q3 | 44 Billion KRW | -36.23% |
| 2015 Q4 | 74 Billion KRW | 68.18% |
| 2015 Q2 | 69 Billion KRW | -30.3% |
| 2015 FY | 124.75 Billion KRW | 94.61% |
| 2014 Q4 | 38.02 Billion KRW | 0.0% |
| 2014 Q3 | 38.02 Billion KRW | 5.2% |
| 2014 FY | 52.11 Billion KRW | 84.68% |
| 2014 Q1 | 21.14 Billion KRW | 2.7% |
| 2014 Q2 | 36.14 Billion KRW | 70.94% |
| 2013 Q3 | 5.89 Billion KRW | -29.92% |
| 2013 FY | 61.1 Billion KRW | 153.28% |
| 2013 Q1 | - KRW | -100.0% |
| 2013 Q2 | 8.4 Billion KRW | 0.0% |
| 2013 Q4 | 20.59 Billion KRW | 249.58% |
| 2012 Q2 | 9.07 Billion KRW | -3.97% |
| 2012 Q1 | 9.45 Billion KRW | 1.97% |
| 2012 FY | 30.5 Billion KRW | -12.32% |
| 2012 Q4 | 8.12 Billion KRW | -6.61% |
| 2012 Q3 | 8.7 Billion KRW | -4.13% |
| 2011 FY | 145.21 Billion KRW | -77.93% |
| 2011 Q4 | 9.27 Billion KRW | -8.03% |
| 2011 Q3 | 10.08 Billion KRW | -73.34% |
| 2011 Q2 | 37.81 Billion KRW | -15.03% |
| 2011 Q1 | 44.5 Billion KRW | 0.0% |
| 2010 Q1 | 66.9 Billion KRW | -9.54% |
| 2010 Q3 | 64.77 Billion KRW | 1.48% |
| 2010 FY | 179.61 Billion KRW | -43.2% |
| 2010 Q2 | 63.82 Billion KRW | -4.61% |
| 2009 Q1 | 78.18 Billion KRW | 1.81% |
| 2009 Q3 | 49.99 Billion KRW | -4.62% |
| 2009 Q2 | 52.41 Billion KRW | -32.95% |
| 2009 Q4 | 73.96 Billion KRW | 47.95% |
| 2009 FY | 73.96 Billion KRW | -3.67% |
| 2008 Q1 | 50 Billion KRW | 11.11% |
| 2008 Q4 | 76.78 Billion KRW | 5.07% |
| 2008 Q3 | 73.08 Billion KRW | 11.72% |
| 2008 Q2 | 65.41 Billion KRW | 30.84% |
| 2008 FY | 76.78 Billion KRW | 70.64% |
| 2007 FY | 105.54 Billion KRW | 0.0% |
| 2007 Q4 | 45 Billion KRW | 29.37% |
| 2007 Q1 | 25 Billion KRW | 0.0% |
| 2007 Q2 | 35 Billion KRW | 40.0% |
| 2007 Q3 | 34.78 Billion KRW | -0.62% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| ORIENT BIO Inc. | 2.43 Billion KRW | -3384.026% |
| Green Cross Holdings Corporation | 216.35 Billion KRW | 60.763% |
| Green Cross Holdings Corporation | 84.89 Billion KRW | 0.0% |
| Pharmicell Co., Ltd. | 390.21 Million KRW | -21654.594% |
| GeneOne Life Science, Inc. | 6.27 Billion KRW | -1253.314% |
| Celltrion, Inc. | 99.13 Billion KRW | 14.367% |
| Samsung Biologics Co.,Ltd. | 377.39 Billion KRW | 77.506% |
| SK bioscience Co.,Ltd. | 12.43 Billion KRW | -582.614% |
| SK Biopharmaceuticals Co., Ltd. | 94.48 Billion KRW | 10.154% |
| Prestige BioPharma Limited | 40.87 Billion KRW | -107.702% |